Increased plasma TSP-2 has been observed in obese patients [27, 28], which may contribute to the development of obesity-related metabolic complications and nephropathy of T2DM [3, 25]. This evidence concerns the gene THBS2 and obesity due to melanocortin 4 receptor deficiency.